Ligand Pharmaceuticals Inc Tr Beta Contingent Value Rt

(LGNZZ)

By |

Profile

Metabasis Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel drugs by applying its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The company's products include: Promacta; Kyprolis.

Contact Information

Website: www.ligand.com
Email: investors@ligand.com
Main Phone: +1 858 587-2770
Address: 9390 Towne Centre Dr. Bldg 300
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: OTO
CEO: John L. Higgins
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.12 $ 0. (0.00%)
Last Price 0.12 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.12
Last Trade Volume 0 52 Wk Hi 0.14 52 Wk Low 0.008
Market Cap 4.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,157,359.00 EPS (TTM) -0.34 PE Ratio N/A Exchange OTCPK